These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 30055522)

  • 21. Towards functional glycomics by localization of binding sites for tissue lectins: lectin histochemical reactivity for galectins during diethylstilbestrol-induced kidney tumorigenesis in male Syrian hamster.
    Saussez S; Lorfevre F; Nonclercq D; Laurent G; André S; Journé F; Kiss R; Toubeau G; Gabius HJ
    Histochem Cell Biol; 2006 Jul; 126(1):57-69. PubMed ID: 16435123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Significance of galectins-1, -3, -4 and -7 in the progression of squamous cell carcinoma of the tongue.
    Alves PM; Godoy GP; Gomes DQ; Medeiros AM; de Souza LB; da Silveira EJ; Vasconcelos MG; Queiroz LM
    Pathol Res Pract; 2011 Apr; 207(4):236-40. PubMed ID: 21397408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of clinicopathological parameters with FoxM1 expression in renal cell carcinoma.
    Kocarslan S; Guldur ME; Ekinci T; Ciftci H; Ozardali HI
    J Cancer Res Ther; 2014; 10(4):1076-81. PubMed ID: 25579557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Leptin and its receptor: can they help to differentiate chromophobe renal cell carcinoma from renal oncocytoma?
    Ng KL; Del Vecchio SJ; Samaratunga H; Morais C; Rajandram R; Vesey DA; Wood ST; Gobe GC
    Pathology; 2018 Aug; 50(5):504-510. PubMed ID: 29970253
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exposed proliferation antigen 210 (XPA-210) in renal cell carcinoma (RCC) and oncocytoma: clinical utility and biological implications.
    Kruck S; Hennenlotter J; Vogel U; Schilling D; Gakis G; Hevler J; Kuehs U; Stenzl A; Schwentner C
    BJU Int; 2012 Feb; 109(4):634-8. PubMed ID: 21711439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced expression of Raf-1 kinase inhibitory protein in renal cell carcinoma: a significant prognostic marker.
    Moon A; Park JY; Sung JY; Park YK; Kim YW
    Pathology; 2012 Oct; 44(6):534-9. PubMed ID: 22935977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human telomerase reverse transcriptase protein expression predicts tumour aggressiveness and survival in patients with clear cell renal cell carcinoma.
    Saeednejad Zanjani L; Madjd Z; Abolhasani M; Rasti A; Shariftabrizi A; Mehrazma M; Fodstad Ø; Asgari M
    Pathology; 2019 Jan; 51(1):21-31. PubMed ID: 30466948
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of galectins in head and neck squamous cell carcinoma.
    Gillenwater A; Xu XC; el-Naggar AK; Clayman GL; Lotan R
    Head Neck; 1996; 18(5):422-32. PubMed ID: 8864733
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunoreactivity of nm23-H1 protein in renal cell carcinoma.
    Kuo JY; Chang KM; Chen KK; Chang LS
    Anticancer Res; 1998; 18(1B):531-6. PubMed ID: 9568173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High cytoplasmic expression of p27(Kip1) is associated with a worse cancer-specific survival in clear cell renal cell carcinoma.
    Kruck S; Merseburger AS; Hennenlotter J; Scharpf M; Eyrich C; Amend B; Sievert KD; Stenzl A; Bedke J
    BJU Int; 2012 May; 109(10):1565-70. PubMed ID: 21981759
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification.
    Zhou M; Yang XJ; Lopez JI; Shah RB; Hes O; Shen SS; Li R; Yang Y; Lin F; Elson P; Sercia L; Magi-Galluzzi C; Tubbs R
    Am J Surg Pathol; 2009 Dec; 33(12):1840-9. PubMed ID: 19898225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of C-reactive protein by renal cell carcinomas and unaffected surrounding renal tissue.
    Jabs WJ; Busse M; Krüger S; Jocham D; Steinhoff J; Doehn C
    Kidney Int; 2005 Nov; 68(5):2103-10. PubMed ID: 16221209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor PDCD4 and promotes cell transformation, proliferation, and metastasis in renal cell carcinoma.
    Li X; Xin S; He Z; Che X; Wang J; Xiao X; Chen J; Song X
    Cell Physiol Biochem; 2014; 33(6):1631-42. PubMed ID: 24902663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinicopathological significance of ganglioside DSGb5 expression in renal cell carcinoma.
    Itoh J; Ito A; Shimada S; Kawasaki Y; Kakoi N; Saito H; Mitsuzuka K; Watanabe M; Satoh M; Saito S; Arai Y
    Glycoconj J; 2017 Apr; 34(2):267-273. PubMed ID: 28205070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating and tissue galectin-1 and galectin-3 in colorectal carcinoma: association with clinicopathological parameters, serum CEA, IL-17 and IL23.
    Petrovic S; Radosavljevic GD; Pantic J; Jovanovic I; Jankovic N; Arsenijevic N
    J BUON; 2016; 21(4):941-949. PubMed ID: 27685917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Value of p53 as a prognostic marker in histologic subtypes of renal cell carcinoma: a systematic analysis of primary and metastatic tumor tissue.
    Zigeuner R; Ratschek M; Rehak P; Schips L; Langner C
    Urology; 2004 Apr; 63(4):651-5. PubMed ID: 15072872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Galectin-8 predicts postoperative recurrence of patients with localized T1 clear cell renal cell carcinoma.
    Liu Y; Xu L; Zhu Y; Zhang W; Liu W; Liu H; Xu J
    Urol Oncol; 2015 Mar; 33(3):112.e1-8. PubMed ID: 25499921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. WWOX protein expression varies among RCC histotypes and downregulation of WWOX protein correlates with less-favorable prognosis in clear RCC.
    Lin JT; Tzai TS; Liao CY; Wang JS; Wu TT; Wang HY; Wu CH; Yu CC; Lu PJ
    Ann Surg Oncol; 2013 Jan; 20(1):193-9. PubMed ID: 22555346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. L-DOPA decarboxylase mRNA levels provide high diagnostic accuracy and discrimination between clear cell and non-clear cell subtypes in renal cell carcinoma.
    Papadopoulos EI; Petraki C; Gregorakis A; Chra E; Fragoulis EG; Scorilas A
    Clin Biochem; 2015 Jun; 48(9):590-5. PubMed ID: 25721989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative immunohistochemical analysis of matrilysin 1 (MMP-7) in various renal cell carcinoma subtypes.
    Patraki E; Cardillo MR
    Int J Immunopathol Pharmacol; 2007; 20(4):697-705. PubMed ID: 18179742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.